Epstein-Barr virus detection in invasive and pre-invasive lesions of the uterine cervix

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 403-405

  Santos, Nelly Beatriz Modós ^a   Villanova, Fabiola Elizabeth ^b   Andrade, Priscila Maria ^b   Ribalta, Julisa ^a   Focchi, José ^a   Otsuka, Audrey Yumi ^b   Silva, Ismael Dale ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cervical cancer; Epstein Barr virus; HPV

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; DNA EXTRACTION; EPSTEIN BARR VIRUS; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; UTERUS CANCER; VAGINA SMEAR; VIROLOGY; VIRUS INFECTION;

BASE SEQUENCE; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; UTERINE NEOPLASMS; VAGINAL SMEARS;

EID: 62849125108     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000236     Document Type: Article

References (25)

1. Macsween KF and Crawford DH: Epstein-Barr virus - recent advances. Lancet Infect Dis 3: 131-140, 2003.
2. Koffa M, Koumantakis E, Ergazaki M, Tsatsanis C and Spandidos DA: Association of herpesvirus infection with the development of genital cancer. Int J Cancer 63: 58-62, 1995.
3. Kurth J, Spieker T, Wustrow J, Strickler GJ, Hansmann LM, Rajewsky K and Küppers R: EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency. Immunity 13: 485-495, 2000.
4. Spano JP, Busson P, Atlan D, Bourhis J, Pignon JP, Esteban C and Armand JP: Nasopharyngeal carcinomas: an update. Eur J Cancer 39: 2121-2135, 2003.
5. Chan AT, Teo PM and Johnson PJ: Nasopharyngeal carcinoma. Ann Oncol 13: 1007-1015, 2002.
6. Niedobitek G, Meru N and Delecluse HJ: Epstein-Barr virus infection and human malignancies. Int J Exp Pathol 82: 149-170, 2001.
7. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G and Joab I: Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91: 1376-1378, 1999.
8. Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, et al: Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 84: 783-790, 2001.
9. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E and Gould VE: Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 62: 4876-4878, 2002.
10. Oda K, Koda K, Takiguchi N, Nunomura M, Seike K and Miyazaki M: Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Gastric Cancer 6: 173-178, 2003.
11. Hsu JL and Glaser SL: Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34: 27-53, 2000.
12. Han AJ, Xiong M and Zong YS: Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China. Am J Clin Pathol 114: 220-226, 2000.
13. Sixbey JW, Lemon SM and Pagano JS: A second site for Epstein-Barr virus shedding: the uterine cervix. Lancet 2: 1122-1124, 1986.
14. Landers RJ, O'Leary JJ, Crowley M, Healy I, Annis P, Burke L, O'Brien D, et al: Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix. J Clin Pathol 46: 931-935, 1993.
15. Se Thoe SY, Wong KK, Pathmanathan R, Sam CK, Cheng HM and Prasad U: Elevated secretory IgA antibodies to Epstein-Barr virus (EBV) and presence of EBV DNA and EBV receptors in patients with cervical carcinoma. Gynecol Oncol 50: 168-172, 1999.
16. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H and Inoue M: Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Hum Pathol 31: 318-326, 2000.
17. Lanham S, Herbert A, Basarab A and Watt P: Detection of cervical infections in colposcopy clinic patients. J Clin Microbiol 39: 2946-2950, 2001.
18. O'Leary JJ, Landers RJ, Crowley M, Healy I, Kealy WF, Hogan J, Cullinane C, et al: Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions. J Clin Pathol 50: 904-910, 1997.
19. Shoji Y, Saegusa M, Takano Y, Hashimura M and Okayasu I: Detection of the Epstein-Barr virus genome in cervical neoplasia is closely related to the degree of infiltrating lymphoid cells: a polymerase chain reaction and in situ hybridization approach. Pathol Int 47: 507-511, 1997.
20. Dillner J, Lenner P, Lehtinen M, Eklund C, Heino P, Wiklund F, Hallmans G, et al: A population-based seroepidemiological study of cervical cancer. Cancer Res 54: 134-141, 1994.
21. Hilton DA, Brown LJ, Pringle JH and Nandha H: Absence of Epstein-Barr virus in carcinoma of the cervix. Cancer 72: 1946-1948, 1993.
22. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, et al: Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 170: 1077-1085, 1994.
23. Herrmann K and Niedobitek G: Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 199: 140-145, 2003.
24. Speck P, Callen DF and Longnecker R: Absence of the Epstein-Barr virus genome in breast cancer-derived cell lines. J Natl Cancer Inst 95: 1253-1254, 2003.
25. Deshpande CG, Badve S, Kidwai N and Longnecker R: Lack of expression of the Epstein-Barr virus (EBV) gene products, EBERs, EBNAI, LMP1, and LMP2A, in breast cancer cells. Lab Invest 82: 1193-1199, 2002.